Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBITDA (2016 - 2025)

Historic EBITDA for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $29.0 million.

  • Exponent's EBITDA rose 1234.57% to $29.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $117.9 million, marking a year-over-year increase of 650.6%. This contributed to the annual value of $119.6 million for FY2025, which is 739.75% up from last year.
  • Per Exponent's latest filing, its EBITDA stood at $29.0 million for Q4 2025, which was up 1234.57% from $17.2 million recorded in Q3 2025.
  • Exponent's EBITDA's 5-year high stood at $45.3 million during Q3 2022, with a 5-year trough of $17.2 million in Q3 2025.
  • Over the past 5 years, Exponent's median EBITDA value was $29.2 million (recorded in 2021), while the average stood at $29.7 million.
  • In the last 5 years, Exponent's EBITDA skyrocketed by 22206.14% in 2021 and then crashed by 5194.44% in 2025.
  • Quarter analysis of 5 years shows Exponent's EBITDA stood at $28.7 million in 2021, then fell by 23.1% to $22.0 million in 2022, then dropped by 16.52% to $18.4 million in 2023, then skyrocketed by 40.52% to $25.8 million in 2024, then rose by 12.35% to $29.0 million in 2025.
  • Its EBITDA was $29.0 million in Q4 2025, compared to $17.2 million in Q3 2025 and $44.4 million in Q2 2025.